Equine platelet lysate shows in vitro antimicrobial activity after lyophilisation and storage

Background Platelet lysate (PL), an emerging biologic therapy, inhibits bacterial growth in vitro. Currently, PL is stored frozen at -80°C, which limits distribution and clinical access. Objectives To assess protein recovery and compare antimicrobial activity of PL before and immediately after lyophilisation, and after room-temperature storage. Study design Experimental in vitro study Methods Three pooled batches of PL from nine healthy equine donors were tested for cytokine content and in vitro efficacy in a time-kill assay as thawed PL, reconstituted freshly lyophilised PL (lyoPL), and reconstituted lyoPL stored for either 2 weeks or 6 months at room temperature (19–21°C). Time-kill assay focused on Escherichia coli and Staphylococcus haemolyticus. Experiments used a 50% (v/v) treatment in bacterial growth medium with phosphate-buffered saline (PBS) as control. Log₁₀ fold-changes in bacterial counts were compared between preparations using linear mixed-effects models and repeated-measures two-way ANOVA, with the pooled batch as the unit of replication (n = 3). Results LyoPL formulations contained similar total protein content to the fresh PL without necessitating addition of a cryobuffer. PDGF-BB was retained after lyophilisation, and immunoreactive CXCL4 (PF4) and CXCL7 concentrations did not differ between PL and lyoPL. Fresh lyoPL and thawed PL showed similar time-kill profiles. LyoPL retained antibacterial activity after 2 weeks and 6 months of storage. Against gram-positive S. haemolyticus, lyoPL and PL showed no significant differences irrespective of storage time and growth inhibition relative to PBS was preserved. Against gram-negative E. coli, PL and lyoPL stored for 2 weeks had a bactericidal effect whereas 6-month stored lyoPL was only bacteriostatic. Main limitations Three pooled batches, two bacterial isolates, one PL concentration, a 4-hour exposure period, and residual moisture not measured. Conclusions Lyophilised PL retained in vitro antimicrobial activity after reconstitution and room-temperature storage, with reduced activity against E. coli after 6 months.

Authors

Institutions

Publication Details

Published
2026-11-10
DOI
https://doi.org/10.22541/authorea.15011919/v1
Primary Topic
Periodontal Regeneration and Treatments
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Equine platelet lysate shows in vitro antimicrobial activity after lyophilisation and storage

John F. Peroni, Julie Gordon, Hannah Arnade, Edward Hunda et al.
Periodontal Regeneration and Treatments
preprint

Equine platelet lysate shows in vitro antimicrobial activity after lyophilisation and storage

John F. Peroni, Julie Gordon, Hannah Arnade, Edward Hunda, Livia Camargo Garbin
preprint en

Abstract

Background Platelet lysate (PL), an emerging biologic therapy, inhibits bacterial growth in vitro. Currently, PL is stored frozen at -80°C, which limits distribution and clinical access. Objectives To assess protein recovery and compare antimicrobial activity of PL before and immediately after lyophilisation, and after room-temperature storage. Study design Experimental in vitro study Methods Three pooled batches of PL from nine healthy equine donors were tested for cytokine content and in vitro efficacy in a time-kill assay as thawed PL, reconstituted freshly lyophilised PL (lyoPL), and reconstituted lyoPL stored for either 2 weeks or 6 months at room temperature (19–21°C). Time-kill assay focused on Escherichia coli and Staphylococcus haemolyticus. Experiments used a 50% (v/v) treatment in bacterial growth medium with phosphate-buffered saline (PBS) as control. Log₁₀ fold-changes in bacterial counts were compared between preparations using linear mixed-effects models and repeated-measures two-way ANOVA, with the pooled batch as the unit of replication (n = 3). Results LyoPL formulations contained similar total protein content to the fresh PL without necessitating addition of a cryobuffer. PDGF-BB was retained after lyophilisation, and immunoreactive CXCL4 (PF4) and CXCL7 concentrations did not differ between PL and lyoPL. Fresh lyoPL and thawed PL showed similar time-kill profiles. LyoPL retained antibacterial activity after 2 weeks and 6 months of storage. Against gram-positive S. haemolyticus, lyoPL and PL showed no significant differences irrespective of storage time and growth inhibition relative to PBS was preserved. Against gram-negative E. coli, PL and lyoPL stored for 2 weeks had a bactericidal effect whereas 6-month stored lyoPL was only bacteriostatic. Main limitations Three pooled batches, two bacterial isolates, one PL concentration, a 4-hour exposure period, and residual moisture not measured. Conclusions Lyophilised PL retained in vitro antimicrobial activity after reconstitution and room-temperature storage, with reduced activity against E. coli after 6 months.

University of Georgia (US)
Periodontal Regeneration and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon